Roberts Mlotkowski Safran & Cole, P.C.
PDE10a inhibitors for the treatment of type II diabetes
Disclosed are compounds, compositions and methods for treating Type II diabetes and other disorders affected by activity of the enzyme PDE10a. Such compounds are represented by Formula (I) below, wherein R1, R2, L and Q are defined herein.
JANSSEN PHARMACEUTICA NV.
A C C
A61P C07D C07D
inventional inventional inventional
Kenneth J. Sanath K. Tianbao Daniel J. Hui Carl R. Yu-Kai Sharmila Jinsheng Mark R.
Wilson Meegalla Lu Parks Huang Illig Lee Patel Chen Player